R-(-)-Manidipine
CAS: 133082-19-6
Ref. 3D-FM25012
1mg | To inquire | ||
2mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire |
Product Information
- (4R)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-[4-(diphenylmethyl)-1-piperazinyl]ethyl methyl ester (-)-Manidipine
- (-)-Manidipine
- (4R)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-[4-(Diphenylmethyl)-1-piperazinyl]ethyl Methyl Ester
- 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-[4-(diphenylmethyl)-1-piperazinyl]ethyl methyl ester, (4R)-
- 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-[4-(diphenylmethyl)-1-piperazinyl]ethyl methyl ester, (4R)- (9CI)
- 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-[4-(diphenylmethyl)-1-piperazinyl]ethyl methyl ester, (R)-
- O3-[2-(4-benzhydrylpiperazin-1-yl)ethyl] O5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
R-(-)-Manidipine is a chiral compound that is metabolized in the body to form two enantiomers, (+)- and (-)-manidipine. The pharmacokinetic study of R-(-)-Manidipine was conducted by comparing the plasma concentrations of the racemic mixture with those of the individual enantiomers. The diastereomeric ratios were determined by analyzing plasma samples using a mass spectrometer and reaction monitoring. The pharmacokinetic study showed that both enantiomers have antihypertensive activity, but (-)-manidipine has higher potency than (+)-manidipine.
Chemical properties
Technical inquiry about: 3D-FM25012 R-(-)-Manidipine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.